Model Informed Drug Development Archives

Publication

BPS Article: Model‐Informed Drug Repurposing: a Pharmacometric Approach to Novel Pathogen Preparedness, Response and Retrospection

Abstract During a pandemic caused by a novel pathogen (NP), drug repurposing offers the potential…

CertaraFebruary 9, 2021

White Paper

Leveraging Biosimulation to Inform Optimal Use of COVID-19 Vaccines

CertaraFebruary 3, 2021

On-Demand Webinar

How drug developers can avoid these common mistakes to secure a deal

Emerging biotech companies sometimes lack all of the experience, expertise, or financial capital to successfully…

CertaraJanuary 21, 2021

On-Demand Webinar

Making your biotech program investor-ready

Emerging biotech companies sometimes lack all of the experience, expertise, or financial capital to successfully…

CertaraJanuary 21, 2021

On-Demand Webinar

An Introduction to Asset Evaluation for Emerging Biotech Companies

Emerging biotech companies sometimes lack all of the experience, expertise, or financial capital to successfully…

CertaraJanuary 21, 2021

Blog

Be Honest, Be Reliable, Be Human: Insights from a Global Drug Development Expert

One of the most exciting things about working in the pharmaceutical industry is the ability…

CertaraDecember 16, 2020

Press Release

Certara Opens New China Office in Shanghai

Office will support rapid growth and collaboration with customers in China to accelerate biopharmaceutical R&D …

CertaraNovember 9, 2020

Blog

Using Model-based Meta-analysis to Inform Neuropathic Pain Drug Development

Model-based Meta-analysis is a framework to compare drugs used to treat diabetic peripheral neuropathy, post-herpetic…

CertaraDecember 19, 2019

Poster

THE RELATIONSHIP BETWEEN mRNA AND ACTIVITY FOLLOWING INDUCTION OF CYP3A4 AND CYP2B6 ACROSS A RANGE OF PROTOTYPICAL INDUCERS

CertaraAugust 28, 2019

Poster

Prediction of Prothrombin Time after Oral Administration of S-Warfarin in Different CYP2C9 Phenotypes in Asian and Caucasian populations using the Simcyp Simulator

CertaraAugust 23, 2019

Model Informed Drug Development

BPS Article: Model‐Informed Drug Repurposing: a Pharmacometric Approach to Novel Pathogen Preparedness, Response and Retrospection

Leveraging Biosimulation to Inform Optimal Use of COVID-19 Vaccines

How drug developers can avoid these common mistakes to secure a deal

Making your biotech program investor-ready

An Introduction to Asset Evaluation for Emerging Biotech Companies

Be Honest, Be Reliable, Be Human: Insights from a Global Drug Development Expert

Certara Opens New China Office in Shanghai

Using Model-based Meta-analysis to Inform Neuropathic Pain Drug Development

THE RELATIONSHIP BETWEEN mRNA AND ACTIVITY FOLLOWING INDUCTION OF CYP3A4 AND CYP2B6 ACROSS A RANGE OF PROTOTYPICAL INDUCERS

Prediction of Prothrombin Time after Oral Administration of S-Warfarin in Different CYP2C9 Phenotypes in Asian and Caucasian populations using the Simcyp Simulator

Newsletter sign up

Quick links

Solutions

Contact